Who is iMediSync?

- iMediSync Inc is a AI-driven early detection therapeutic platform for optimal brain health.

- iMediSync originated from National Standard Data Center for Korean EEG, Seoul National University which has developed Asia’s first QEEG normative DB with more than 1300 healthy subjects ranging from 4 – 90 years old.

- iSyncBrain® (https://isyncbrain.com) is an AI driven analysis cloud platform. It has been registered as a class II medical device by the Korean FDA, and users from more than 30 countries are using the platform. 
- Our early detection EEG algorithm for aMCI, “iSyncBrain – MCI Classifier” was developed and clinically validated with three Korean university hospitals (sensitivity, specificity >90%). It also got the clearance from Korean FDA as a class II medical device for (different underlying pathology)

- iSyncHeart® is an AI cloud-based solution for heart rate variability (HRV). It was launched and has been registered as a class II medical device by the Korean FDA. It has been used for remote ECG monitoring of participants in clinical trials.

- iSyncBrain® and iSyncHeart® platform are primarily used by doctors and clinical psychologists for research purposes. And it will be expanded for virtual telemental care by June 2021. 

- The vision of iMediSync is to develop early detecting biomarkers for challenging neurological disorders such as Parkinson’s disease, TBI, PTSD, ADHD, and Depression.  


iMediSync

Org chart

Teams

Offices

iMediSync

Org chart

Teams

Offices

Related companies